Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer02:18

Cancer

51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Cancer Prevention02:59

Cancer Prevention

6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Prevention02:59

Cancer Prevention

2.6K
2.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
Cancer Therapies02:49

Cancer Therapies

8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
What is Cancer?02:12

What is Cancer?

12.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
12.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of the cf-MMSP assay for enhanced analytical sensitivity of methylated DNA in breast cancer liquid biopsy.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Tri-APBI: Single Institution Phase I/II Prospective Clinical Trial of Three Fraction Accelerated Partial Breast Irradiation for Stage 0-I Breast Cancer.

Practical radiation oncology·2026
Same author

Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171.

Cancer·2026
Same author

Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial.

JCO oncology advances·2026
Same author

Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2).

NPJ breast cancer·2026
Same author

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2<sup>+</sup> breast cancer: TBCRC049 phase 2 study results.

Nature cancer·2026
Same journal

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.3K

Breast cancer version 3.2014.

William J Gradishar, Benjamin O Anderson, Sarah L Blair

    Journal of the National Comprehensive Cancer Network : JNCCN
    |April 11, 2014
    PubMed
    Summary
    This summary is machine-generated.

    This article discusses National Comprehensive Cancer Network (NCCN) Guidelines for managing large breast cancer tumors (stages II and III). Patient participation in clinical trials is recommended for optimal breast cancer treatment.

    More Related Videos

    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
    06:03

    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

    Published on: February 6, 2020

    6.0K
    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    8.6K

    Related Experiment Videos

    Last Updated: May 1, 2026

    Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
    08:08

    Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

    Published on: June 11, 2014

    15.3K
    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
    06:03

    Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

    Published on: February 6, 2020

    6.0K
    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    8.6K

    Area of Science:

    • Oncology
    • Clinical Medicine

    Background:

    • Breast cancer is a leading cause of cancer death in US women.
    • Management involves local (surgery, radiation) and systemic (chemotherapy, endocrine, biologic therapy) treatments.

    Purpose of the Study:

    • To discuss the NCCN Guidelines for managing large clinical stage II and III breast cancer tumors.
    • To emphasize the role of expert clinical judgment in applying these guidelines.

    Main Methods:

    • Review of NCCN Guidelines developed by the NCCN Breast Cancer Panel.
    • Focus on management strategies for advanced-stage breast cancer.

    Main Results:

    • The article details NCCN Guidelines for large stage II and III breast cancer.
    • Expert medical judgment is crucial for individualized patient care.

    Conclusions:

    • NCCN Guidelines provide a framework for managing advanced breast cancer.
    • Patient participation in clinical trials is the preferred treatment option across all stages.